VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 10/01/2021
** VAERS DATABASE Last updated: October 1, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.






Manufacturers

Total Manufacturer

Incidents per State

State Total
92,076
AK1,880
AL6,345
AR4,151
AS46
AZ14,991
CA66,887
CO12,550
CT8,943
DC1,795
DE2,009
FL42,724
FM4
GA17,031
GU124
HI2,580
IA4,919
ID2,892
IL22,128
IN24,197
KS5,047
KY9,111
LA5,500
MA15,718
MD13,434
ME3,351
MH8
MI20,971
MN13,585
MO10,747
MP30
MS3,198
MT2,477
NC18,051
ND1,501
NE3,109
NH3,218
NJ20,216
NM4,218
NV4,728
NY37,667
OH20,793
OK6,692
OR9,244
PA25,607
PR2,588
QM2
RI2,163
SC7,261
SD1,282
TN10,445
TX39,890
UT4,618
VA15,980
VI67
VT1,830
WA16,071
WI12,042
WV2,571
WY926
XB5
XL1
XV2

ID: 1537046
Sex: M
Age: 81
State: CA

Vax Date: 02/14/2021
Onset Date: 02/14/2021
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (difficulty breathing), HYPERHIDROSIS (lots of sweating), PAIN IN EXTREMITY (leg pain, a lot of pain), CHILLS (chills) and NAUSEA (minor nausea) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Glaucoma (patient taking hydrox for glaucoma.). Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication. On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced DYSPNOEA (difficulty breathing), HYPERHIDROSIS (lots of sweating), PAIN IN EXTREMITY (leg pain, a lot of pain), CHILLS (chills), NAUSEA (minor nausea) and PYREXIA (fever of 100 and 101?F). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DYSPNOEA (difficulty breathing), HYPERHIDROSIS (lots of sweating), PAIN IN EXTREMITY (leg pain, a lot of pain), CHILLS (chills), NAUSEA (minor nausea) and PYREXIA (fever of 100 and 101?F) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Feb-2021, Body temperature: 100 ?F (High) 100-101?F and then came down to 99 after one day. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication taken by the patient included cholesterol medicine, hydrox for glaucoma. Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021: Follow up information was received and the outcome of the events were updated to recovered.

Other Meds: ASPIRIN [ACETYLSALICYLIC ACID]

Current Illness: Glaucoma (patient taking hydroxy for glaucoma.)

ID: 1537047
Sex: F
Age:
State: PR

Vax Date: 02/05/2021
Onset Date: 02/13/2021
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of CONDITION AGGRAVATED (flared up), VACCINATION SITE SWELLING (injection site swollen) and VACCINATION SITE ERYTHEMA (injection site redness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced VACCINATION SITE SWELLING (injection site swollen) and VACCINATION SITE ERYTHEMA (injection site redness). On 19-Feb-2021, the patient experienced CONDITION AGGRAVATED (flared up). The patient was treated with CORTISONE for Vaccination site erythema and Vaccination site swelling, at an unspecified dose and frequency. At the time of the report, CONDITION AGGRAVATED (flared up), VACCINATION SITE SWELLING (injection site swollen) and VACCINATION SITE ERYTHEMA (injection site redness) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No relevant concomitant medications were provided. The redness was spreading throughout the upper arm.

Other Meds:

Current Illness:

ID: 1537048
Sex: F
Age: 78
State: MI

Vax Date: 01/22/2021
Onset Date: 02/02/2021
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a consumer and describes the occurrence of INDURATION (Hard spot) and RASH (Slight rash at that point) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20H) for COVID-19 vaccination. No Medical History information was reported. On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 02-Feb-2021, the patient experienced INDURATION (Hard spot) and RASH (Slight rash at that point). At the time of the report, INDURATION (Hard spot) outcome was unknown and RASH (Slight rash at that point) had not resolved. Not Provided The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment medications were reported.

Other Meds:

Current Illness:

ID: 1537049
Sex: F
Age:
State:

Vax Date: 12/23/2020
Onset Date:
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Pain and heat at the injection site; Pain and heat at the injection site; Mild muscle / joint pain; Mild muscle / joint pain; A spontaneous report was received from a consumer concerning a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) experienced pain and heat at the injection site and mild muscle / joint pain. The patient's medical history was not provided. Concomitant product use was not provided by the reporter. On 23 Dec 2020, prior to the onset of the symptoms, the patient received their planned dose of mRNA-1273 (Batch number not provided) intramuscularly for prophylaxis of COVID-19 infection. On unknown date, the patient experienced pain and heat the injection site. She also experienced mild muscle and joint pain. Treatment information was not provided. Action taken with mRNA-1273 in response to the events was not provided. The outcome of the events pain and heat at the injection site and mild muscle / joint pain were unknown.; Reporter's Comments: This case concerns a female of unknown age who experienced a NS unexpected events of injection site warmth and NS expected events of injection site pain, myalgia, arthralgia. The events occurred with unknown latency after the first dose of mRNA-1273. Treatment not reported. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1537050
Sex: F
Age: 70
State: NY

Vax Date: 01/24/2021
Onset Date:
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: itchy arm, leg and stomach; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchy arm, leg and stomach) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included CALAMINE, GLYCEROL, ZINC OXIDE (CALAMINE LOTION) for Itching. On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (itchy arm, leg and stomach). At the time of the report, PRURITUS (itchy arm, leg and stomach) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment information was not reported.

Other Meds: CALAMINE LOTION

Current Illness:

ID: 1537051
Sex: F
Age: 78
State: NY

Vax Date: 02/12/2021
Onset Date:
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Could not raise arm after injection; Rash on stomach across from belly button like a strip; Tiny Rash at injection site; Sore at injection site; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (Could not raise arm after injection), RASH (Rash on stomach across from belly button like a strip), INJECTION SITE RASH (Tiny Rash at injection site) and INJECTION SITE PAIN (Sore at injection site) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MUSCULAR WEAKNESS (Could not raise arm after injection), RASH (Rash on stomach across from belly button like a strip), INJECTION SITE RASH (Tiny Rash at injection site) and INJECTION SITE PAIN (Sore at injection site). At the time of the report, MUSCULAR WEAKNESS (Could not raise arm after injection), RASH (Rash on stomach across from belly button like a strip), INJECTION SITE RASH (Tiny Rash at injection site) and INJECTION SITE PAIN (Sore at injection site) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medications were not provided. Treatment information was not reported.

Other Meds:

Current Illness:

ID: 1537052
Sex: M
Age:
State: CA

Vax Date:
Onset Date:
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: upset stomach; chills; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (upset stomach) and CHILLS (chills) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (upset stomach) and CHILLS (chills). At the time of the report, ABDOMINAL DISCOMFORT (upset stomach) and CHILLS (chills) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication use was provided by the reporter. No treatment of events was reported. This case was linked to US-MODERNATX, INC.-MOD-2021-036232 (E2B Linked Report). This case was linked to MOD21-045496, MOD21-045539 (Patient Link).; Sender's Comments: US-MODERNATX, INC.-MOD-2021-036232:

Other Meds:

Current Illness:

ID: 1537053
Sex: F
Age: 76
State:

Vax Date: 02/26/2021
Onset Date:
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: arm is still hot; Hard skin, leathery; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (arm is still hot) and VACCINATION SITE INDURATION (Hard skin, leathery) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0C1A21A) for COVID-19 vaccination. The patient's past medical history included Melanoma and Septicemia (Blood poisoning). Concurrent medical conditions included Sensitive skin, Psoriasis and Bone density abnormal. Concomitant products included ALENDRONATE SODIUM (FOSAMAX) for Bone density abnormal. On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (arm is still hot) and VACCINATION SITE INDURATION (Hard skin, leathery). At the time of the report, VACCINATION SITE WARMTH (arm is still hot) and VACCINATION SITE INDURATION (Hard skin, leathery) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. The patient reported treatment of events was with antibiotic cream and allergen on an unknown start date.

Other Meds: FOSAMAX

Current Illness: Bone density abnormal; Psoriasis; Sensitive skin

ID: 1537054
Sex: F
Age:
State: WI

Vax Date: 02/10/2021
Onset Date: 03/10/2021
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous case was reported by a health care professional and describes the occurrence of VACCINATION SITE DISCOLOURATION (Three inch pink patch under the injection site that is warm to the touch), FATIGUE (More tired than usual) and VACCINATION SITE RASH (Three inch pink patch under the injection site) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included SOTALOL for an unknown indication. On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 10-Mar-2021, the patient experienced VACCINATION SITE DISCOLOURATION (Three inch pink patch under the injection site that is warm to the touch), FATIGUE (More tired than usual) and VACCINATION SITE RASH (Three inch pink patch under the injection site). At the time of the report, VACCINATION SITE DISCOLOURATION (Three inch pink patch under the injection site that is warm to the touch), FATIGUE (More tired than usual) and VACCINATION SITE RASH (Three inch pink patch under the injection site) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment information was not provided. Action taken with mRNA-1273 in response to the events was not Applicable.

Other Meds: SOTALOL

Current Illness:

ID: 1537055
Sex: F
Age: 31
State: CO

Vax Date: 12/24/2020
Onset Date: 12/24/2020
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Arm soreness; Breast feeding; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm soreness) and EXPOSURE VIA BREAST MILK (Breast feeding) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025J20-2A and 029L20A) for COVID-19 vaccination. The patient's past medical history included Gestational hypertension. Concurrent medical conditions included Alcohol use (occasionally). Concomitant products included NATURE MADE MULTI PRENATAL from 09-Jan-2019 to an unknown date for Breast feeding, PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] and FISH OIL (OMEGA 3 [FISH OIL]) for an unknown indication. On 24-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Dec-2020, the patient experienced PAIN IN EXTREMITY (Arm soreness) and EXPOSURE VIA BREAST MILK (Breast feeding). On 27-Dec-2020, PAIN IN EXTREMITY (Arm soreness) had resolved and EXPOSURE VIA BREAST MILK (Breast feeding) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Patient stated that she was exclusively breast feeding her 10 month old baby who was born on 09-09-2020 (4 weeks early, 34 weeks+ 2days f gestation). No associated adverse events reported. This case was linked to MOD-2020-001985 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 20-May-2021: F/U-1 : VAERS, Dose 2 Vaccination date, Date of Birth; Reporter's Comments: This is a case of product exposure during breastfeeding with no associated AEs. Patient will continue to be contacted for further monitoring of AEs

Other Meds: PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS ; OMEGA 3 [FISH OIL]; NATURE MADE MULTI PRENATAL

Current Illness: Alcohol use (occasionally)

ID: 1537056
Sex: U
Age:
State: GA

Vax Date: 12/31/2020
Onset Date:
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Increased body temperature; Heartbeat increased; A spontaneous report was received from a consumer of an unspecified age and gender, who received Moderna's COVID-19 vaccine and experienced increased body temperature and heartbeat. There were no medical history and concomitant medications reported. On 31 Dec 2020, prior to the onset of the event, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection. Patient reported that he began to experience increased body temperature and heartbeat. No treatment information was provided. Action taken with mRNA-1273 in response to the events were not reported. The outcome of events increased body temperature and heartbeat was unknown.; Reporter's Comments: This case concerns a patient of unknown age and gender. The medical history is not provided. The patient experienced non-serious unexpected events of Body temperature increased and Heart rate increased at on unknown date after receiving their first of two planned doses of mRNA-1273 (Lot unknown). Based on the current available information and temporal association between the use of the product and the onset of the events, a causal relationship cannot be excluded and the events are considered possibly related to the vaccine.

Other Meds:

Current Illness:

ID: 1537057
Sex: F
Age: 37
State: OH

Vax Date: 12/24/2020
Onset Date: 12/25/2020
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Firmer; Itchy; Bruising; a lot of pain in her arm; red circle on arm; A report was received from a pharmacist concerning a 37-year old, female patient who was participating in the mRNA-1273 Emergency Use Program and experienced pain, red circle, itchy, firmer and bruising on her arm. The patient's medical history, as provided by the reporter, included Hashimoto's disease and rosacea. Concomitant medications reported included levothyroxine. On 24 Dec 2020, hours prior to the onset of the events, pain in her arm and red circle on arm, approximately 7 days prior to the onset of the event, bruising, and 8 days prior to the onset of the events itchy and firmer, the patient received her first of two planned doses of mRNA-1273 (LOT number 011j20a) intramuscularly in the left arm for prophylaxis of COVID-19 infection. On 25 Dec 2020 around midnight, the patient noticed she had a lot of pain in her arm and had a red circle, which grew over the next few days. On 31 Dec 2020, she noticed bruising. On 01 Jan 2020, the patient noticed a wider red oval on her arm that measured 3 inches long and 1.5 inches tall, and was itchy and firmer. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. The outcomes of the events were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds: LEVOTHYROXINE

Current Illness: Hashimoto's disease; Rosacea

ID: 1537058
Sex: F
Age:
State: CA

Vax Date: 12/31/2020
Onset Date: 12/31/2020
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Left side of her face was numb; Her feet were itchy; Puffiness underneath both her eyes, itchiness underneath bothe her eyes, left eye worse; Right side of her face was numb; Bottom lip was swollen; Underneath her eyes were swollen; Hives on her stomach; Left side of her face has been numb; Left side of her face has been tingling; A spontaneous report was received from a consumer concerning a female patient of an unknown age who received Moderna's COVID-19 vaccine and experienced numbness on the left side of her face/hypoaesthesia and tingling/paraesthesia, eyes were swollen/eye swelling, itchiness underneath both of her eyes/eye pruritus, lip was swollen/lip swelling, and her feet were itchy/pruritus, Hives on her stomach/hives. The patient's medical history and concomitant product use were not provided by the reporter. On 31 Dec 2020, the same day as the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 via unknown route for prophylaxis of COVID-19 infection. On 31 Dec 2020 the patient developed numbness on the left side of her face and experienced tingling. On 09 Jan 2021 the patient experienced hives on her stomach as well as swelling and itchiness under hear eyes. She treated the events with diphenhydramine and was better the next day. On 19 Jan 2021 the patient experienced itchiness and puffiness underneath her eyes again. She also reported the right side of her face became numb and her bottom lip was swollen for approximately 12 hours. She treated the events with diphenhydramine again and the events subsided. On 21 Jan 2021 the left side of her face was numb. Her feet were itchy, and she treated the event with ice and elevation. Action taken with mRNA-1273 in response to the events was not provided. The outcome of the events face was numb, face was tingling was considered as unknown. The outcome of the events eyes were swollen, itchiness underneath both of her eyes, lip was swollen, and feet were itchy, hives on stomach was considered as resolved. The reporter did not provide causality for the events. Additional information received on 22 Jan 2021 included additional events and treatments.; Reporter's Comments: This case concerns a female of unknown age who had with NS events of unexpected urticaria, hypoesthesia, paresthesia, eye pruritus, eye swelling, lip swelling, and expected pruritus. Event onset occurred the same day as the first dose of mRNA-1273. Treatment included diphenhydramine. Event s resolved. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1537059
Sex: F
Age:
State: TN

Vax Date: 12/23/2020
Onset Date: 12/23/2020
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: left arm is tingling; swelling, redness at old BCG site with tenderness; swelling, redness at old BCG site with tenderness; itching below injection site/itching in the injection area; pain in the injection site right away/myalgia local pain; A spontaneous report was received from a physician, who was also the patient, that received Moderna's COVID-19 vaccine (mRNA-1273) and experienced vaccine injection site itching, tingling, vaccine injection site swelling, vaccine injection site redness and vaccine injection site pain. The patient's medical history was not provided. No concomitant medications were reported. On 23-Dec 2020, the patient received their first of two planned doses of mRNA-1273 intramuscularly in the left arm for prophylaxis of COVID-19 infection. On 23-Dec-2020, the patient experienced injection site pain that resolved right away. On 31-Dec-2020, the patient experienced itching and redness where she previously received a vaccine many years ago. She took Tylenol for those symptoms. On 01-Jan-2021, the patient experienced swelling at the injection site that went away. She also experienced random itching in the left arm area. On 04-Jan-2021, the patient's left upper arm was tingling. Action taken with mRNA-1273 in response to the events was not reported. The outcome of the events, injection site itching, tingling and injection site redness was not recovered/resolved. The outcome of the events, injection site pain and injection site swelling, was recovered/resolved.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1537060
Sex: F
Age: 28
State: MD

Vax Date: 12/29/2020
Onset Date: 12/29/2020
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Heart racing; Freaking out; Feeling like she was dying; Not functioning well; A spontaneous report was received from a healthcare facility staff member (United States) concerning a 28-year-old, female patient who was participating in the mRNA-1273 Emergency Use Program and who experienced her heart racing, was freaking out, and was feeling like she was dying. The patient's medical history included a heart murmur, panic attacks, post-traumatic stress disorder, pneumonia and diarrhea. Concomitant product use was denied by the reporter. The patient received their first of two planned doses of mRNA-1273 (LOT# 025J20A) on 29-Dec-2020 intramuscularly in the for prophylaxis of COVID-19 infection. Patient received the Moderna vaccine on 29-Dec-2020. Approximately 2 hours after vaccine administration while driving to another job, she experienced her heart racing, said she was freaking out and feeling like she was dying. She stated that her heart rate, at one point, reached 142 beats per minute and also stated that her pulse-oximetry remained between 97-98%. Three days later on 01-Jan-2021, she reported still having these symptoms, however, they were more spaced out. She stated that at one point, she had experienced panic while showering and said that she has not been functioning well. Patient said that she has had a lot of anxiety about the pandemic. Treatment information was not provided. Action taken with mRNA-1273 in response to the events, her heart racing, was freaking out, and was feeling like she was dying, was not provided. The outcome of the events, her heart racing, was freaking out, and was feeling like she was dying, were considered as unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. The patient's medical history of panic attacks, PTSD and heart murmur confounds causality. Patient said that she has had a lot of anxiety about the pandemic which is risk factor for panic attack.

Other Meds:

Current Illness: Heart murmur; Panic attack; Post-traumatic stress disorder

ID: 1537061
Sex: F
Age:
State:

Vax Date: 12/30/2020
Onset Date:
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Sore arm; Fever; A report was received from a consumer concerning a 26-year old, female patient who was participating in the mRNA-1273 Emergency Use Program and developed sore arm and fever. The patient's medical history was not provided. No relevant concomitant medications were reported. On 30 Dec 2020, the patient received their first of two planned doses of mRNA-1273 (LOT or BATCH number 011320A) intramuscularly for prophylaxis of COVID-19 infection. On an unknown date, the patient experienced sore arm that lasted about 1 day, and fever which lasted about 5 hours. No treatment information was provided. Action taken with mRNA-1273 in response to the events was unknown. The events, sore arm and fever, were considered resolved on an unknown date.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1537062
Sex: F
Age: 66
State: FL

Vax Date: 12/31/2020
Onset Date: 01/01/2021
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: slightly itchy; little bit of a rash; knot at the site of injection; A report was received from a consumer concerning a 66-year old, female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced knot at the site of injection (vaccination site induration), rash (vaccination site rash), and slightly itchy (vaccination site pruritis). The patient's medical history, as provided by the reporter, included left shoulder replacement. Concomitant medications reported included paracetamol. On 31 Dec 2020, approximately 1 day prior to the onset of the event, knot at the site of injection, and 3 days prior to the onset of the events, rash and slightly itchy, the patient received their first of two planned doses of mRNA-1273 intramuscularly in the right arm for prophylaxis of COVID-19 infection. On 01 Jan 2021, the patient felt a knot at the site of the injection in her right arm, which she described as big "like somebody punched you". On 03 Jan 2020, the patient had a rash, that was slightly itchy around it. On 04 Jan 2020, the knot and itching had resolved, though there was still some rash. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. The events, knot at the site of injection and itching, were considered resolved on 04 Jan 2021. The outcome of the event, rash, was unknown. Follow-up received on 05 Jan 2021 included the patient's initial report, updating the initial receipt date to 01 Jan 2020.; Reporter's Comments: This case concerns a 66-year-old female who experienced NS expected events of vaccination site rash, vaccination site pruritus, vaccination site induration. Event onset occurred Day 2 after the first dose of mRNA-1273. Based on current available information and temporal association between the use of the product and the start date of the vaccination site rash, vaccination site pruritus, vaccination site induration, a causal relationship cannot be excluded.

Other Meds: TYLENOL EXTRA STRENGTH

Current Illness:

ID: 1537063
Sex: F
Age: 47
State: CA

Vax Date: 12/28/2020
Onset Date: 12/28/2020
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: A spontaneous report, was received from a nurse practioner (patient), a 47 year-old female patient, unknown race and ethnicity, who received Moderna's COVID-19 Vaccine (mRNA-1273), and experienced numbness in both legs, hands and both arms (hypoaesthesia), tingling pins and needles in both legs, hands and both arms (paraesthesia), felt like cramps in legs (muscle spasms). The patient's medical history was not provided. Concomitant medications reported included montelukast sodium, levothyroxine, and salbutamol sulfate. On 28 Dec 2020, prior to the onset of events, the patient received their first of two planned doses of mRNA-1273 (Batch number: 039K20A), intramuscularly in the left arm for COVID-19 for infection prophylaxis. The patient reported that she received the vaccine on 28 Dec 2020 around 2:00 pm. On the same day at around 5:00 pm, she started feeling numbness and tingling pins and needles in legs. She stated that it felt like cramps. The patient reported that she took acetaminophen and leg cramps OTC and was better and able to sleep at night. On 29 Dec 2020, the patient went to occupational health at her work and reported the incident. She stated that she took acetaminophen and ibuprofen around the clock. On 31 Dec 2020, the patient experienced numbness and tingling on her hands. She confirmed that it was both legs and both arms that were affected. The patient reported that her primary care doctor was aware. On 02 Jan 2021, the patient stated that it was then almost a week and the numbness, pain, and tingling were still there. The patient stated that she took ibuprofen at 12:00 pm that day and the cramps were on and off. She reported that she was concerned and would like a follow up call. The patient also gave consent to follow up with her doctor. Action taken with second dose of mRNA-1273 in response to the events was not reported. The outcome of the events, numbness in both legs, hands and both arms, tingling pins and needles in both legs, hands and both arms, and felt like cramps in legs, were considered as not resolved.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds: SINGULAIR; LEVOTHYROXINE; INHALERIN

Current Illness:

ID: 1537064
Sex: F
Age: 29
State: TX

Vax Date: 12/28/2020
Onset Date: 01/01/2021
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swelling of the lymph node; Injection site discomfort; Injection site pain; A spontaneous report, was received from a pharmacist (patient), a 29 years-old female patient, unknown race and ethnicity, who received Moderna's COVID-19 Vaccine (mRNA-1273), and experienced injection site discomfort, swelling of the lymph node (lymphadenopathy), and injection site pain. The patient's medical history was not provided. No relevant concomitant medications were reported. On 28 Dec 2020, for days prior to the onset of events, the patient received their first of two planned doses of mRNA-1273 (lot number: 025L20A), intramuscularly in the left deltoid for prophylaxis of COVID-19 infection. On 01 Jan 2021, the patient began to experience swelling of the lymph node, injection site pain and discomfort. The symptoms were still ongoing. Currently, the patient has not received any treatment for her symptoms and wants to know if she can take any medication to treat her symptoms. Action taken with second dose of mRNA-1273 in response to the events was not reported. The outcome of the event events, swelling of the lymph node, injection site pain and discomfort, were considered as not recovered/not resolved.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1537065
Sex: F
Age: 53
State: VA

Vax Date: 12/26/2020
Onset Date: 12/26/2020
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Itches a little; Red dots on injection Site; Pain and tenderness at injection site; A spontaneous report was received from a dental hygienist, who was a 53-year-old, female patient who experienced vaccination site pain, vaccination site erythema and vaccination site pruritus. The patient's medical history was not provided. Concomitant product use was not provided by the reporter. On 26-Dec-2020, the patient received their first of two planned doses of mRNA-1273 (Lot number 039K20A) intramuscularly in the left deltoid for prophylaxis of COVID-19 infection. The patient reported that she received her first shot of the Moderna Covid-19 Vaccine on 26-Dec-2020 and went through the normal side effects of pain and tenderness in the injection site. These events resolved. On 02-Jan-2021, she observed red dots on the injection site. The next day, 03-Jan-2021, she reported that the red dots were connected and that the red area looked a "little bigger than a golf ball" (about 2.5") on the injection site. The patient reported that it itched, but not much. Treatment information was not provided. Action taken with mRNA-1273 in response to the events was not provided. The outcome of the event, vaccination site pain, was considered recovered/resolved. The outcome of the events, vaccination site erythema and vaccination site pruritus, were considered unknown.; Reporter's Comments: This case concerns a 53-year-old female who had nonserious expected event of vaccination site erythema, vaccination site pain, vaccination site pruritus. Event onset the same day as the first dose of mRNA-1273. Based on current available information and temporal association between use of the product and the start date of the vaccination site erythema, vaccination site pain, vaccination site pruritus, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1537066
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Blood pressure high; High heart rate; A spontaneous report was received from a reporter, concerning a female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experience high blood pressure and heart rate. The patient's medical history was not provided. No relevant concomitant medications were reported. On an unknown date, the patient received their first of two planned doses of mRNA-1273 (Lot number unknown) intramuscularly for prophylaxis of COVID-19 infection. On an unknown date, the reporter stated that his step-mother who received the vaccine, experienced an adverse side effect of high blood pressure and heart rate which lasted about 2 hours. The reported mentioned that the patient was being monitored in the hospital where she received the vaccine. No treatment was information was provided. Action taken with mRNA-1273 in response to the event was not reported. The outcome of events, high blood pressure and heart rate, were unknown. The Follow up information was received on 11 Mar 2021. No new information was provided.; Reporter's Comments: This case concerns a female patient of unknown age, who experienced the non-serious unlisted events of Hypertension and Heart rate increased. The events occurred on unknown date after receiving their first of two planned doses of mRNA-1273 (Lot unknown). Based on the current available information and temporal association between the use of the product and the onset of events on the day of vaccination, a causal relationship cannot be excluded and the events are considered possibly related to the vaccine.

Other Meds:

Current Illness:

ID: 1537067
Sex: M
Age: 23
State: CA

Vax Date: 01/02/2021
Onset Date: 01/03/2021
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Numbness above right eye; Headache; A spontaneous report was received from a consumer concerning a 23 years old male patient who received Moderna's COVID-19 vaccine and experienced numbness above his right eye and headache after receiving the Moderna COVID-19 vaccine. There were no medical history and concomitant medications reported. On 02 Jan 20201, the patient received his first of two planned doses of mRNA-1273 vaccine (batch# 025J20-2A) intramuscularly in the right arm for prophylaxis of COVID-19 infection. On 03 JAN 2021, he reported that he had experienced numbness above the right eye and a headache after receiving the vaccine. The exact time interval between the vaccine administration and the event was not provided. The patient received no treatment and the symptoms resolved the same day. Action taken with mRNA-1273 in response to the events were not reported. The outcome of the events were considered resolved on 03 Jan 2021.; Reporter's Comments: This case concerns a 23 year-old, male patient, who experienced events of numbness above his right eye and headache. The events occurred the next day after the first and last dose of mRNA-1273 vaccine administration. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded and the events are assessed as possibly related.

Other Meds:

Current Illness:

ID: 1537068
Sex: F
Age: 76
State: TX

Vax Date: 12/31/2020
Onset Date: 01/03/2021
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Hard time breathing; A spontaneous report was received from a consumer who is a 76 year old female patient who received Moderna's COVID-19 Vaccine and experienced a hard time breathing. The patient's medical history was not provided. Concomitant medications, provided by the reporter, include Labetalol 200mg and Propafenone 150mg. On 31 Dec 2020, approximately 3 days prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Batch number 037520A) intramuscularly for prophylaxis of COVID-19 infection. On 03 Jan 2021, the patient had a hard time breathing. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not provided. The outcome of the event, hard time breathing, was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds: LABETALOL; PROPAFENONE

Current Illness:

ID: 1537069
Sex: M
Age: 57
State: OH

Vax Date: 12/31/2020
Onset Date: 01/03/2021
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Excruciating pain in left hip, progressed to shoulders, wrist, left neck; Unable to hold/lift his phone; A spontaneous report was received from a consumer who was an 57-year-old, male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced excruciating pain in left hip, shoulders, wrist, left neck and unable to hold/lift his phone. The patient's medical history was not provided. No concomitant medications were reported. On 31 Dec 2020, prior to the onset of the events, the patient received his first of two planned doses of mRNA-1273 (Lot number: 039K20/2A) intramuscularly for prophylaxis of COVID-19 infection. On 03 Jan 2021, the patient experienced excruciating pain in left hip, shoulders, wrist, left neck and unable to hold/lift his phone. The patient reported he went to emergency room (ER) but was discharged. Treatment for the events included paracetamol and ibuprofen. The patient also stated that the pain medications have not been helpful. Action taken with mRNA-1273 in response to the events was not provided. The outcome for the events, excruciating pain in left hip, shoulders, wrist, left neck and unable to hold/lift his phone was considered as not recovered/not resolved.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1537070
Sex: F
Age:
State:

Vax Date: 12/24/2020
Onset Date: 12/31/2020
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: hot to the touch; a lot of redness; very itchy; swelling; A spontaneous report was received from a consumer concerning a female patient who was participating in the mRNA-1273 Emergency Use Program and experienced a lot of redness, swelling, hot to the touch and very itchy. The patient's medical history was not provided. No relevant concomitant medications were reported. On 24 Dec 2020, approximately 7 days prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection. On 31 Dec 2020, the patient reported having a lot of redness, swelling, hot to the touch, and very itchy. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. The outcomes of the events, a lot of redness, swelling, hot to the touch and very itchy were unknown.; Reporter's Comments: This case concerns a female of unknown age who had NS events of unexpected injection site warmth and expected injection site erythema, injection site pruritus, injection site swelling. Event onset occurred 8 days after first dose mRNA-1273. Based on current available information and temporal association between use of the product and the start date of the injection site swelling, injection site warmth, injection site erythema, injection site pruritus, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1537071
Sex: F
Age:
State: RI

Vax Date: 12/29/2020
Onset Date: 01/05/2021
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Redness has gotten bigger; it feeling a little bit warm; redness on the right arm; Hardness when she touches the injected area; A spontaneous report was received from a healthcare facility staff member concerning a 49-year-old female patient who was participating in the mRNA-1273 Emergency Use Program and developed hardness, and redness, over the injected area. The patient's medical history was not provided. Concomitant product use was not provided by the reporter. The patient received their first of two planned doses of mRNA-1273 (LOT# unknown) on 29-Dec-2020 intramuscularly in the right arm for prophylaxis of COVID-19 infection. Patient received the Moderna vaccine on 29-Dec-2020 in the right arm.. On 05-Jan-2021, she reported that she had hardness when she touched the injected area. On 06-Jan-2021, she reported that she had some redness on her right arm and that it felt warm. Additionally, she stated that the nurse had circled the red area earlier and that she noticed that it had gotten bigger over the course of the day. Treatment information was not provided. Action taken with mRNA-1273 in response to the event, injected site hardness, redness, warm on the right arm, and the redness has gotten bigger over the course of the day, was not provided. The outcome of the events, Injected site hardness, redness, warm, the redness has gotten bigger over the course of the day, was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1537072
Sex: M
Age:
State: FL

Vax Date: 12/29/2020
Onset Date:
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Some tenderness; A spontaneous report was received from a consumer concerning a male patient who received Moderna's COVID-19 vaccine and experienced some tenderness. The patient's medical history was not provided. No relevant concomitant medications were reported. On 29 Dec 2020, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection. On an unknown date, the patient reported having no reaction, just some tenderness for a few days. No treatment information was reported. Action taken with mRNA-1273 in response to the event is not appplicable. The outcome of the event was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1537073
Sex: F
Age: 59
State: CT

Vax Date: 12/28/2020
Onset Date: 12/28/2020
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: area around the injection site became red; area around the Injection site became hot; area around the injection site became itchy; area around the Injection site became swollen; lumps on and under the clavical that are super super sensative; Little bumps when touched lightly around the lymph nodes; arm was sore; A spontaneous report was received from a consumer concerning a 59 year-old, female patient who received Moderna's COVID-19 vaccine and experienced sore arm, injection site "red, hot, swollen, and itchy", and lumps on and under the clavicle. The patient's medical history was not provided. Concomitant medication includes a multivitamin. On 28 Dec 2020, the patient received their first of two planned doses of mRNA-1273 (011J20A) intramuscularly in the left deltoid for prophylaxis of COVID-19 infection. On 28 Dec 2020, the patient reported having a sore arm for 2-3 days. On 03 Jan 2021, the patient's injection site became red, hot, swollen, and itchy. The symptoms did not worsen, but are ongoing and have not gotten better. The patient also reported lumps on and under the clavicle on the left side, around the lymph nodes that are "super, super sensitive". Treatment included ibuprofen. Action taken with mRNA-1273 in response to the event was not reported. The outcome of the events, sore arm, injection site "red, hot, swollen, and itchy", and lumps on and under the clavicle was considered not recovered/not resolved; Reporter's Comments: This case concerns a 59-year-old female who had nonserious events of unexpected injection site warmth and expected injection site erythema, injection site pain, injection site swelling, injection site pruritus, lymphadenopathy, and lymph node pain. Treated with ibuprofen. Event onset occurred the same day as the first dose of mRNA-1273. Based on current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds: MULTIVITAMIN [VITAMINS NOS]

Current Illness:

ID: 1537074
Sex: F
Age:
State:

Vax Date: 12/29/2020
Onset Date: 12/30/2020
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Metal taste; A spontaneous report was received from a consumer concerning a female patient who experienced a metal taste (dysgeusia). The patient's medical history was not provided. No relevant concomitant medications were reported. On 29 Dec 2020, the patient received their first of two planned doses of mRNA-1273 for prophylaxis of COVID-19 infection. On 30 Dec 2020, the patient reported having a metal taste in her mouth that is ongoing and doesn't stop. No treatment information was provided. Action taken with mRNA-1273 in response to the event was not reported. The event, metal taste, was considered not recovered.; Reporter's Comments: This case concerns a female of unknown age who had a nonserious unexpected event of dysgeusia. Event onset occurred 2 days after the first dose of mRNA-1273. Event ongoing. Based on current available information and temporal association between the use of the product and the start date of the dysgeusia, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1537075
Sex: F
Age:
State:

Vax Date: 12/21/2020
Onset Date: 12/01/2020
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Felt overall sickness; Pain down her back and arm; Pain down her back and arm; Woke up feeling like ball in armpit, got an ultra sound and discovered there were four oversized lymph nodes.; Muscle area where received the shot with sore with some tightness; Brain fog; Fever; Fatigue; Malaise; A spontaneous report was received from an adult female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced muscle area where received the shot with sore with some tightness (vaccination site pain), woke up feeling like ball in armpit, got an ultrasound and discovered there were four oversized lymph nodes (lymphadenopathy), felt an overall sickness (illness), fatigue, malaise, brain fog (feeling abnormal), fever (pyrexia), and felt pain down her back and arm (back pain/pain in extremity). There was no medical history provided. There were no concomitant medications provided. On 21 Dec 2020, the patient received the first of two planned doses of mRNA-1273 (Lot # unknown) intramuscularly, for prophylaxis of COVID-19 infection. On 23 Dec 2020, the patient experienced muscle area where received the shot was sore with some tightness. On 26 Dec 2020, she woke up feeling like there was a ball in armpit, got an ultrasound and discovered there were four oversized lymph nodes. It was noted the largest lymph node was 5cm and was very painful. On unknown dates in Dec 2020, the patient felt an overall sickness, fatigue, malaise, brain fog, and fever, and the symptoms have been slowly dissipating. On 28 Dec 2020, described as the worst day, she felt pain down her back and arm. There was no further treatment information provided. Relevant laboratory on unknown date in December 2020, included an ultrasound which showed four oversized lymph nodes. Action taken with mRNA-1273 in response to the reported events was not reported. The events of felt an overall sickness, fatigue, malaise, brain fog, fever were reported as recovering at the time of this report. The outcome for the remaining events, woke up feeling like ball in armpit, got an ultrasound and discovered there were four oversized lymph nodes, and felt pain down her back and arm was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1537076
Sex: F
Age:
State: TX

Vax Date: 12/31/2020
Onset Date: 01/01/2021
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: like a lump; Rashes 1-2 inch below the injection site; swollen; injection site irreregular; A spontaneous report was received from a consumer a female patient who experienced rashes 1-2 inches below the injection site, an irregular in shape and swollen lump-like injection site. The patient's medical history was not provided. Concomitant product use was not provided/unknown by the reporter On 31 Dec 2020, the patient received their first of two planned doses of mRNA-1273 (Lot number not provided by administration site, per patient) intramuscularly in the left arm for prophylaxis of COVID-19 infection. Treatment information was not provided/unknown. Action taken with mRNA-1273 in response to the events was not provided/unknown. The outcome of the events rashes 1-2 inches below the injection site, an irregular in shape and swollen lump-like injection site were unknown/not reported.; Reporter's Comments: This case concerns a female of unknown age who had NS events of unexpected vaccination site mass and expected vaccination site swelling, vaccination site induration, vaccination site rash. Event onset 2 days after first dose mRNA-1273. Based on current available information and temporal association between use of the product and the start date of the Vaccination site mass, vaccination site swelling, vaccination site induration and vaccination site rash, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1537077
Sex: F
Age:
State: MA

Vax Date: 12/29/2020
Onset Date: 01/01/2021
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: A spontaneous report was received from a consumer concerning a 63-year-old, female patient, who received Moderna's COVID-19 Vaccine and experienced feeling extremely dizzy, headache, soreness of the arm and fatigue. The patient's medical history was not provided. No relevant concomitant medications were reported. On 29 Dec 2020, prior to the onset of events, the patient received their dose of mRNA-1273 (Batch Number: 026126A) for prophylaxis of COVID-19 infection. On 01-Jan-2021, the patient experienced feeling extremely dizzy, headache, soreness of the arm and fatigue. No treatment information was provided Action taken with mRNA-1273 in response to the events feeling extremely dizzy, headache, soreness of the arm and fatigue was not reported. The outcome of the events feeling extremely dizzy, headache, soreness of the arm and fatigue was not reported.; Reporter's Comments: Based on the current available information and a strong temporal association between the use of the product, the known safety profile of the vaccine and the start date of the reported events, a causal relationship with the events cannot be excluded. Headache and fatigue. are consistent with the known safety profile of mRNA-1273.

Other Meds:

Current Illness:

ID: 1537078
Sex: F
Age: 29
State: OH

Vax Date: 12/31/2020
Onset Date: 12/31/2020
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: A spontaneous report was received from a 30-year-old, female healthcare facility staff member who received Moderna's COVID-19 vaccine (mRNA-1273) and developed nausea, lightheadedness, headaches, numbness of injection arm and loss of sense of taste. The patient's medical history was not provided. No relevant concomitant medications were reported. On 31-Dec-2020, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 intramuscularly in the right arm for prophylaxis of COVID-19 infection. On 31-Dec-2020, after receiving vaccine, patient reported nausea, lightheadedness, headaches, numbness of injection arm that lasted for a few hours. On 01-Jan-2021, patient lost her sense of taste and was tested for COVID-19. Patient's rapid COVID-19 test was negative and she is waiting results from a PCR test she took 04-Jan-2021. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. The outcomes of the events, nausea, lightheadedness, headaches, numbness of injection arm and loss of sense of taste, were considered recovered/resolved.; Reporter's Comments: This case concerns a 29-year-old female who had nonserious events of unexpected ageusia, hypoaesthesia, dizziness and expected headache, nausea. Event onset occurred the same day as the first dose of mRNA-1273. Based on current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1537079
Sex: M
Age:
State:

Vax Date: 12/31/2020
Onset Date:
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fever; adverse reaction; A spontaneous report was received from a male patient who received Moderna's COVID-19 Vaccine and experienced adverse reaction and fever. The patient's medical history was not provided. No concomitant medications were reported. On 31 Dec 2020, the patient received the first of two planned doses of mRNA-1273 for COVID-19 for infection prophylaxis. On an unknown date, the patient began having an adverse reaction. He reported that he had a fever and some other symptoms. Treatment for the event was not reported. Action taken with mRNA-1273 in response to the events was not reported. The outcome of the events, adverse reaction and fever, was considered unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event pyrexia, a causal relationship cannot be excluded. Further information has been requested regarding the unnamed 'adverse reaction' event.

Other Meds:

Current Illness:

ID: 1537080
Sex: F
Age:
State: CA

Vax Date: 12/28/2020
Onset Date:
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: loss of taste; A spontaneous report was received from a consumer concerning a female patient who received Moderna's COVID-19 vaccination (mRNA-1273) and who experienced loss of taste. The patient's medical history was not provided. No concomitant medications were reported. On 28-Dec-2020, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection. On 28-Dec-2020, the patient experienced loss of taste. No treatment information was provided. Action taken with mRNA-1273 vaccine was not provided. The outcome of the event, loss of taste, was considered unknown.; Reporter's Comments: This case concerns a female of unknown age who had a NS event of unexpected ageusia. Event onset occurred the same day as the first dose of mRNA-1273. Based on current available information and temporal association between use of the product and the start date of the ageusia, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1537081
Sex: F
Age:
State: TN

Vax Date: 12/30/2020
Onset Date: 12/31/2020
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Dizziness; Naseua; Vomiting; She experienced a really bad headache; A spontaneous report was received from a consumer who was a female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and who experienced a really bad headache, nausea, vomiting and dizziness. The patient's medical history was not provided. Concomitant product use was not provided by the reporter. The patient received their first of two planned doses of mRNA-1273 on 30-Dec-2020 intramuscularly in the left shoulder for prophylaxis of COVID-19 infection. Patient received their Moderna vaccine on 30-Dec-2020 at the Health Department in the left shoulder. One day later, on 31-Dec-2020, she reported a bad headache which was resolved by the next day, 01-Jan-2021. She continued to feel normal on 01-Jan-2021, however, on 02-Jan-2021, she again reported experiencing a bad headache as well as nausea and vomiting, all of which were resolved by 03-Jan-2021. She stated that she was fine for the remainder of that day. Finally, on 04-Jan-2021, she reported that experienced nausea and dizziness. Treatment for the event included paracetamol for symptom management. Action taken with mRNA-1273 in response to the events was not provided. The outcomes of the events, a really bad headache and vomiting, were considered recovered/resolved. The outcomes of the events, nausea and dizziness, were considered unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested

Other Meds:

Current Illness:

ID: 1537082
Sex: F
Age:
State: NJ

Vax Date: 12/30/2020
Onset Date: 12/30/2020
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (18 weeks pregnant) in a female patient of an unknown age (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20A) for COVID-19 vaccination. Concurrent medical conditions included Asthma, Psoriasis, Anxiety, Depression and Drug allergy (Patient reported drug allergy to quinolones.). Concomitant products included LORATADINE (CLARITINE) and MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication. On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 04-Jun-2021. On 30-Dec-2020, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (18 weeks pregnant). On 30-Dec-2020, MATERNAL EXPOSURE DURING PREGNANCY (18 weeks pregnant) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. There was no treatment medication reported. The patient's had one previous pregnancy which was a live full term birth Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds: CLARITINE; PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]

Current Illness: Anxiety; Asthma; Depression; Drug allergy (Patient reported drug allergy to quinolones.); Psoriasis

ID: 1537083
Sex: F
Age: 57
State:

Vax Date: 12/28/2020
Onset Date: 12/30/2020
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Chest feels like what if feels before getting a chest cold; Cough; Significant pain at the injection site; Felt tired; This spontaneous case was reported by a consumer and describes the occurrence of CHEST DISCOMFORT (Chest feels like what if feels before getting a chest cold), COUGH (Cough), VACCINATION SITE PAIN (Significant pain at the injection site) and FATIGUE (Felt tired) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The patient's past medical history included No adverse event (No reported medical history). On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Dec-2020, the patient experienced FATIGUE (Felt tired). On an unknown date, the patient experienced CHEST DISCOMFORT (Chest feels like what if feels before getting a chest cold), COUGH (Cough) and VACCINATION SITE PAIN (Significant pain at the injection site). At the time of the report, CHEST DISCOMFORT (Chest feels like what if feels before getting a chest cold), COUGH (Cough), VACCINATION SITE PAIN (Significant pain at the injection site) and FATIGUE (Felt tired) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1537084
Sex: F
Age: 79
State: TX

Vax Date: 12/23/2020
Onset Date: 12/30/2020
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: A spontaneous report was received from a consumer who was a 79-year-old, female patient who received Moderna's Covid-19 vaccine (mRNA-1273) and experienced intermittent headache, crushing feeling in her chest between her breast, red, swollen arm and had pain shooting down to the elbow and felt very fatigued. The patient's medical history was not provided. Concomitant product use was not provided by the reporter. The patient received their first of two planned doses of mRNA-1273 (Lot # 037N20A) on 23-Dec-2020 in the left deltoid intramuscularly for prophylaxis of COVID-19 infection. The consumer called to report she had received the Moderna Covid-19 vaccine on 23-Dec-2020 in her left deltoid. She stated she did not have any reaction until 30-Dec-2020. She began to experience intermittent headache, a crushing feeling in her chest between her breast. She stated the crushing feeling was not pain, only lasted 10-15 seconds and was intermittent. She stated her arm began to get red, swollen and had pain shooting down to the elbow. She stated she felt very fatigued. Her son took her to Urgent care where she had a chest x-ray, blood work, an electrocardiogram and her vitals were taken. There were no specific results of these tests reported, but the patient reported that everything "checked out good." She reported that on 02-Jan-2021, all of the symptoms went away except for the red, sore arm. She stated that that continued. The consumer reported her symptoms online through VAERS system. Treatment included a topical steroid cream on the injection site which was not prescribed. Action taken with mRNA-1273 in response to the events was not provided. The outcomes of the events, intermittent headache, crushing feeling in her chest between her breast, swollen arm, pain shooting down to the elbow, and felt very fatigued, were considered resolved as of 02-Jan-2021. The outcome of the event, red, sore arm, was considered unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested

Other Meds:

Current Illness:

ID: 1537085
Sex: F
Age:
State:

Vax Date: 12/23/2020
Onset Date: 12/31/2020
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Swelling at the vaccination site; A spontaneous report was received from a female consumer of unknown age, who was also the patient, who received Moderna's COVID-19 vaccine and experienced swelling at the site. The patient's medical history was not provided. Concomitant product use was not provided by the reporter. On 23 Dec 2020, the patient received their first of two planned doses of mRNA-1273 (Lot number: Unknown) for prophylaxis of COVID-19 infection. On the night of 31 Dec 2020, the patient developed swelling of the site of the VCG vaccination they received in the remote past. Treatment information was not provided. Action taken with mRNA-1273 in response to the events was unknown. The outcome for the event swelling at the site was unknown.; Reporter's Comments: This case concerns a female of unknown age who had a NS event of expected Vaccination site swelling. Event onset occurred Day 9 after the first dose of mRNA-1273. Based on current available information and temporal association between use of the product and the start date of the Vaccination site swelling, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1537086
Sex: M
Age: 59
State: OK

Vax Date: 12/30/2020
Onset Date: 12/31/2020
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Neck sore; Sleeping all day yesterday and today; Spot 2in below the site of injection; Left arm sore; Left shoulder sore; A spontaneous report was received from a consumer concerning himself, a 59-year-old, male patient who experienced a sore neck [Neck pain], sleepiness [Somnolence], a spot 2 inches below the injection site [vaccination site reaction], soreness in left arm [Pain in extremity] and soreness in shoulder [Arthralgia]. The patient's medical history was not provided. Concomitant product use was not provided by the reporter. On 30-Dec-2020, approximately one day prior to the onset of the symptoms, the patient received one of two planned doses of mRNA-1273 (Lot unknown) intramuscularly in the left arm for prophylaxis of COVID-19 infection. On 31-Dec-2020, the patient reported he noticed a spot 2 inches below the site of the injection. He also reported that his shoulder, arm and neck are sore, and he has been sleeping all day for two days. He was unable to provide the lot number received due to the number being unclear. Treatment information was not provided. Action taken with mRNA-1273 in response to the events was not provided. The outcomes of the events were not reported; Reporter's Comments: This case concerns a 59 Y/O M with a nonserious unexpected event of neck pain, somnolence, and expected vaccination site reaction, pain in extremity and arthralgia. Event onset 2 days after the first dose of mRNA-1273. Treatment not reported. Event outcomes unknown. Based on current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1537087
Sex: F
Age:
State:

Vax Date: 12/26/2020
Onset Date: 01/03/2021
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Slight rash around the injection site; Slight itchiness on my left arm near the injection site; A spontaneous report was received from a 27-year-old female consumer who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced slight itchiness on her left arm near the injection site [vaccination site pruritus] and a very slight rash around the injection site [vaccination site rash]. The patient's medical history was not provided. Concomitant product use was not provided by the reporter. On 26-Dec-2021, approximately 8 days prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Lot number unknown) intramuscularly in the left arm for prophylaxis of COVID-19 infection. On 03-Jan-2021, the patient noticed a slight itchiness of her left arm near the injection site. On 04-Jan-2021, she also noticed a very slight rash around the injection site. Treatment information was not provided. Action taken with mRNA-1273 in response to the events was not provided. The outcome of the events was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the reported events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1537088
Sex: F
Age:
State: TX

Vax Date: 01/02/2021
Onset Date: 01/02/2021
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Unable to get out of bed because of dizziness; High blood pressure; 145/84 now; Sore arm; A report was received from a consumer concerning a 59-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced unable to get out of bed because of dizziness (dizziness), sore arm (vaccination site pain), and high blood pressure (hypertension). The patient's medical history and concomitant medications were not reported. On 02 Jan 2021, approximately six hours prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot #: unknown) intramuscularly for prophylaxis of COVID-19 infection. The patient was unable to get out of bed because of dizziness, had a sore arm, and high blood pressure (145/84) beginning on 02 Jan 2021. No treatment information was provided. Action taken with mRNA-1273 in response to the events was not reported. The outcome of the events, unable to get out of bed because of dizziness, sore arm, and high blood pressure, was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested

Other Meds:

Current Illness:

ID: 1537089
Sex: M
Age:
State:

Vax Date: 12/31/2020
Onset Date: 01/01/2021
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Upper temple site on the left side of the head, it is a lot of pain; Lot of joint pain in the knees and elbows; A spontaneous report was received from a consumer concerning an unknown age, male patient, who received Moderna's COVID-19 Vaccine and experienced woke up in the morning with a severe headache in the upper temple site on the left side of the head and a lot of joint pain in the knees and elbows. The patient's medical history was not provided. No relevant concomitant medications were reported. On 31 Dec 2020, prior to the onset of events, the patient received their dose of mRNA-1273 (Batch Number: Unknown) for prophylaxis of COVID-19 infection. On 1 Jan 2021, in morning the patient experienced severe headache in the upper temple site on the left side of the head and a lot of joint pain in the knees and elbows. No treatment information was provided. Action taken with mRNA-1273 in response to the events, severe headache in the upper temple site on the left side of the head and a lot of joint pain in the knees and elbows was not reported. The outcome of the events, severe headache in the upper temple site on the left side of the head and a lot of joint pain in the knees and elbows was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. Further information has been requested

Other Meds:

Current Illness:

ID: 1537090
Sex: F
Age:
State: TX

Vax Date: 12/31/2020
Onset Date: 12/31/2020
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Feeling really fatigued and tired; A lot of muscle aches; Nausea; Arm really, really sore; A spontaneous report was received from a healthcare facility staff member concerning a 42-year old, female patient who was participating in the mRNA-1273 Emergency Use Program and experienced fatigue and tiredness, sore arm, muscle aches, and nausea. The patient's medical history was not provided. Concomitant medications reported included bupropion hydrochloride. On 31 Dec 2020 the patient received their first of two planned doses of mRNA-1273 (Lot number OZSLZ0A) intramuscularly in the right arm for prophylaxis of COVID-19 infection. On 01 Jan 2021, the patient's arm was sore and she experienced fatigue and nausea that lasted a few hours. On 03 Jan 2021 the patient began to experience muscle aches. On 04 Jan 2020, the patient reported the soreness to be gone but the fatigue had gotten worse and not improved with rest. Treatment for the event included ibuprofen, which per the patient, alleviated some of the soreness and aches and pains. Action taken with mRNA-1273 in response to the events was not reported. The event, nausea, was considered resolved on 01 Jan 2021. The event sore arm was considered resolved on 04 Jan 2021. The outcomes of the events, feeling fatigued and tired and muscle aches, were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds: WELLBUTRIN

Current Illness:

ID: 1537091
Sex: F
Age:
State: IN

Vax Date: 12/31/2020
Onset Date: 12/31/2020
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: fatigue; Vomiting; nausea; teeth were chattering, had chills; Fever; Joint pains; Headache; starting to itch; arm hurts; arm is red; A spontaneous report was received from a healthcare professional who was also a female patient of unknown age who received Moderna's Covid-19 vaccine (mRNA-1273) and developed fatigue, nausea, chills, vomiting, fever (pyrexia), joint pains (arthralgia), arm hurts (pain in extremity), arm is red (erythema), itch (pruritus), and headache. Historical condition included tested positive for Covid on 13 Dec 2021. Concomitant product use was not provided by the reporter. On 31 Dec 2021, at 11 am, the patient received their first of two planned doses of mRNA-1273 (Lot number: not provided) for prophylaxis of COVID-19 infection. The patient felt fine until 11 pm on 31 Dec 2021, when she felt fatigue and nauseas. Later on, her teeth were chattering, had chills, vomiting, fever and joint pains. She stated she stopped vomiting on 01 Jan 2021 (reported as Friday) but still had fever and headache. She stated her arm was red and started to itch. Treatment for the events were not provided. Action taken with mRNA-1273 in response to the events was not provided. The event of vomiting was resolved on 01 Jan 2021. The events of fever and headache were not resolved at the time of this report. The outcome of the events of fatigue, nausea, chills, joint pains, arm hurts, arm is red, and itch was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1537092
Sex: M
Age: 67
State: MS

Vax Date: 12/29/2020
Onset Date: 01/02/2021
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Cough; Tested positive for COVID 19; Fever; A spontaneous report was received from a consumer (physician) concerning a 67-year-old, male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced cough, fever and tested positive for COVID-19. The patient's medical history included cough. No relevant concomitant medications were reported. On 29 Dec 2020, prior to the onset of the events, the patient received his first of two planned doses of mRNA-1273 (Batch Number Unknown) intramuscularly for prophylaxis of COVID-19 infection. On 29 Dec 2020, the patient's cough continued since receiving mRNA-1273. On 02 Jan 2021, the patient developed fever and tested positive for COVID-19. Treatment details included paracetamol. Action taken with mRNA-1273 in response to the events was not reported. The outcome of the event cough was considered not recovered (still having a cough). The outcome of the event fever was considered recovering . The outcome of the event tested positive for COVID-19 was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. However, the event of Covid-19 is Unlikely related to mRNA-1273 and a very limited information regarding this event has been provided. Further information has been requested

Other Meds:

Current Illness: Cough (Had a cough prior to taking the vaccine)

ID: 1537093
Sex: F
Age:
State:

Vax Date: 12/23/2020
Onset Date: 01/01/2021
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Redness at injection site; A spontaneous report was received from a nurse (patient), a female patient of unknown age, unknown race and ethnicity, who received Moderna's COVID-19 Vaccine (mRNA-1273), and experienced redness at injection site (injection site redness). The patient's medical history was not provided. No concomitant medications were reported. On 23 Dec 2020, prior to the onset of event, the patient received their first of two planned doses of mRNA-1273 (lot number: unknown), intramuscularly for prophylaxis of COVID-19 infection. The patient reported that still today on 01 Jan 2021, she has redness at the site that was very localised at the injection site was about an inch to inch and a half in size and almost square sort of shape. The patient does not have any other symptoms or discomforts. No treatment information was provided. Action taken with second dose mRNA-1273 in response to the event was not reported. The outcome of the event, redness at injection site, was not recovered/resolved.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

ID: 1537094
Sex: F
Age:
State:

Vax Date: 12/01/2020
Onset Date: 12/01/2020
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: 20 weeks pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. In December 2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication details were reported. No treatment medication details was reported.; Reporter's Comments: This is a case of product exposure during pregnancy with no associated AEs for this unidentified female. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.

Other Meds:

Current Illness:

ID: 1537095
Sex: F
Age:
State: TX

Vax Date: 12/30/2020
Onset Date: 12/30/2020
Rec V Date: 08/09/2021
Hospital:

Vax Type:
Manufacturer:
Vax Name:
Lot:
Dose Series:
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List:

Symptoms: Fever of 99.6; Chills; Right arm pain at the injection site; Nausea; A spontaneous report, was received from a healthcare professional (patient), a 62 year old female patient, unknown race and ethnicity, who received Moderna's COVID-19 Vaccine (mRNA-1273) and experienced nausea, fever of 99.6 (pyrexia), chills, and right arm pain at the injection site (injection site pain). The patient's medical history was not provided. No relevant concomitant medications were reported. On 30 Dec 2020, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot# 011J20A), intramuscularly in the right arm for prophylaxis of COVID-19 infection. On 30 Dec 2020, after administration of the vaccine, the patient developed nausea, fever of 99.6 with chills, and right arm pain at the injection site. No treatment information was provided. Action taken with first dose of mRNA-1273 in response to the events was not reported. The outcome of the events, nausea, fever of 99.6, chills, and right arm pain at the injection site, were unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 704,237

Page last modified: 03 October 2021 5:28pm